Surface Logix Adds $20 Million
Surface Logix Inc., a Brighton, Mass.-based developer of drug optimization programs, has raised around $15 million in fifth-round funding. Return backers include ARCH Venture Partners, HBM BioVentures, Healthcare Focus, Intel Capital, Saudi Venture Development Co., Unilever Technology Ventures and Venrock. The company also secured a $5 million venture loan from Silicon Valley Bank. Prior to this funding, Surface Logix had raised around $75 million in venture capital.
9 March 2009•3 mins read
